Mia's Feed
Medical News & Research

Socio-Economic Disparities in Dementia Care in Quebec

Socio-Economic Disparities in Dementia Care in Quebec

Share this article

A groundbreaking study uncovers significant socio-economic disparities in dementia care in Quebec, revealing unequal access and treatment outcomes despite universal healthcare. The research emphasizes the urgent need for equitable health policies.

2 min read

A recent comprehensive study highlights significant disparities in dementia care across socioeconomic lines in Quebec, despite the province's universal healthcare system. Led by Dr. Claire Godard-Sebillotte from McGill University, the research is the first large-scale investigation into how social determinants influence dementia treatment outcomes in the region.

The study examined health records of approximately 200,000 individuals diagnosed with dementia between 2000 and 2017. Patients were monitored for a year or until death or institutionalization. To assess socioeconomic status, the researchers utilized a material deprivation index that evaluates neighborhoods based on income, education levels, and employment rates.

Findings revealed that residents in impoverished neighborhoods were substantially more prone to hospitalization, emergency room visits, and were more likely to be prescribed potentially inappropriate medications such as antipsychotics or benzodiazepines. These medications not only pose risks like falls and confusion but also indicate possible inequalities in care. Conversely, individuals from wealthier areas had increased access to specialized cognitive healthcare and regular consultations with dementia specialists.

The persistence of these healthcare disparities over nearly two decades raises questions about equity in Quebec’s healthcare system. Dr. Godard-Sebillotte emphasizes that equity does not mean uniform treatment but tailoring care to individual needs.

The study suggests that those in poorer areas may be in worse overall health by the time of diagnosis, reducing their ability to benefit from healthcare services. Limited access to home support services and caregiver assistance might contribute to a reliance on medications as a management strategy.

These findings have prompted policy discussions, with researchers collaborating with Quebec’s health authorities to address disparities. The Quebec Policy on Alzheimer’s Disease aims to reduce inequities in dementia care, an approach that is notably proactive compared to international standards.

Looking ahead, the research team plans to explore how factors such as racialization, language barriers, and rural residence intersect with poverty to further impact healthcare access and outcomes.

Understanding and addressing these socioeconomic barriers is critical to ensuring equitable dementia care for all populations in Quebec.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

PET Imaging Reveals Brain Inflammation Linked to Speech Disorders and Parkinson-like Symptoms

New PET imaging research uncovers brain inflammation patterns associated with speech impairments and Parkinson-like symptoms in neurodegenerative disorder PAOS, offering insights for early diagnosis and targeted treatments.

Research Finds Hepatitis B Immunity May Reduce Diabetes Risk

A new study reveals that immunity to hepatitis B virus, achieved through vaccination, may decrease the risk of developing diabetes, especially among younger adults. This discovery suggests additional health benefits of HBV vaccination beyond infection prevention.

Night Light and Circadian Disruption: Impacts on Cardiovascular Health

New research links brighter night-time light exposure to increased risks of cardiovascular diseases, emphasizing the importance of circadian alignment for heart health. Find out how artificial light affects your cardiovascular risk factors.

Discovery of a Key Enzyme in Cell Movement and Cancer Spread

Scientists from the University of Konstanz have identified PPM1F as a vital enzyme that controls cell migration, playing a significant role in tissue development and tumor spread. This discovery opens new avenues for cancer therapy research.